I also noticed the NVS news and was thinking NVS must be ready to move forward with something. I'm not an expert on the NVS pipeline, or approved drug portfolio, but I think they only have a few Oncology products including Gleevec. I am not aware of any MAb's. IMGN needs a catalyst to drive some new buying volume. Looking forward to the investor day meeting/presentation next week, maybe we will learn more then.